CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.

A former labor and delivery nurse, Lindy Sledge, 62, lives with her family in Franklin, Kentucky. She has mantle cell lymphoma.

Here are latest arrivals approved by the Food and Drug Administration.

Tecartus led to durable remission in a majority of participants in a Phase II study.